ifenprodil has been researched along with Central Nervous System Diseases in 1 studies
ifenprodil: NMDA receptor antagonist
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chazot, PL | 1 |
1 review available for ifenprodil and Central Nervous System Diseases
| Article | Year |
|---|---|
The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies.
Topics: Animals; Binding Sites; Central Nervous System Diseases; Cognition; Drug Delivery Systems; Humans; N | 2004 |